
Comet shares dropped 2.2% following a downgrade by UBS from Buy to Neutral, with the bank citing slowing growth prospects and weaker-than-expected demand in the company’s semiconductor business. UBS lowered its price target to CHF194, anticipating "material sales growth deceleration" due to consumer spending uncertainty and reduced capital expenditures from semiconductor equipment customers. This revised outlook suggests Comet's current share price now appropriately reflects tempered growth expectations, leading to a balanced upside and downside potential.
Comet's shares declined 2.2% following a significant downgrade from UBS, which moved its rating from Buy to Neutral and reduced its price target to CHF194. The downgrade is predicated on a deteriorating outlook for Comet's semiconductor business, with UBS citing weaker-than-expected demand improvements, consumer spending uncertainty, and hesitancy from semiconductor equipment customers to increase capital expenditures. This outlook marks a material shift from the bank's previous thesis, which anticipated a stronger demand recovery and contributions from a new RF generator product. UBS now forecasts a "material sales growth deceleration," which is expected to limit the company's operating leverage and margin expansion. According to the bank's reverse DCF analysis, Comet's current valuation already reflects these lowered growth estimates, suggesting that both upside and downside potential are now balanced.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.60
Ticker Sentiment